X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1088) 1088
Publication (107) 107
Book Review (27) 27
Book Chapter (17) 17
Conference Proceeding (3) 3
Government Document (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (841) 841
improved survival (718) 718
index medicus (710) 710
female (503) 503
male (461) 461
surgery (422) 422
middle aged (376) 376
oncology (336) 336
aged (315) 315
adult (287) 287
treatment outcome (262) 262
cancer (229) 229
retrospective studies (210) 210
prognosis (196) 196
analysis (166) 166
chemotherapy (166) 166
care and treatment (165) 165
aged, 80 and over (155) 155
mortality (149) 149
neoplasm staging (147) 147
health aspects (132) 132
medicine & public health (128) 128
research (122) 122
risk factors (115) 115
survival rate (115) 115
metastasis (108) 108
follow-up studies (102) 102
melanoma (100) 100
radiotherapy (99) 99
management (94) 94
patients (93) 93
survival (93) 93
adolescent (89) 89
abridged index medicus (88) 88
carcinoma (86) 86
gastroenterology & hepatology (81) 81
pediatrics (79) 79
survival analysis (79) 79
animals (77) 77
combined modality therapy (75) 75
tumors (75) 75
prospective studies (72) 72
child (68) 68
hematology, oncology and palliative medicine (68) 68
radiation-therapy (68) 68
young adult (66) 66
disease-free survival (65) 65
therapy (65) 65
outcomes (64) 64
prognostic-factors (63) 63
improved outcomes (61) 61
time factors (60) 60
antineoplastic combined chemotherapy protocols - therapeutic use (57) 57
article (57) 57
diagnosis (57) 57
patient outcomes (56) 56
colorectal cancer (55) 55
cohort studies (54) 54
child, preschool (53) 53
resection (52) 52
chemotherapy, adjuvant (51) 51
infant (51) 51
medical prognosis (51) 51
metastatic melanoma (50) 50
radiology, nuclear medicine & medical imaging (49) 49
usage (49) 49
medicine (48) 48
studies (48) 48
children (47) 47
experience (47) 47
medicine, general & internal (47) 47
proportional hazards models (47) 47
follow-up (46) 46
medical research (46) 46
multivariate analysis (46) 46
recurrence (46) 46
colorectal-cancer (45) 45
kaplan-meier estimate (44) 44
obstetrics & gynecology (44) 44
antineoplastic agents - therapeutic use (42) 42
radiation (42) 42
total mesorectal excision (42) 42
cardiac & cardiovascular systems (41) 41
epidemiology (41) 41
open-label (41) 41
orthopedics (41) 41
immunotherapy (40) 40
pharmacology & pharmacy (40) 40
squamous-cell carcinoma (40) 40
clinical trials (39) 39
hematology (39) 39
metastases (39) 39
mutation (39) 39
trial (39) 39
infant, newborn (38) 38
melanoma - drug therapy (38) 38
neoadjuvant therapy (38) 38
rectal neoplasms - surgery (38) 38
adjuvant chemotherapy (37) 37
medical colleges (37) 37
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Neuro-Oncology, ISSN 0167-594X, 01/2019, Volume 141, Issue 1, pp. 159 - 166
Background High-volume hospitals are associated with improved outcomes in glioblastoma (GBM). However, the impact of travel burden to high-volume centers is... 
Hospital volume | Travel distance | Survival | Outcomes | Glioblastoma | UNITED-STATES | MORTALITY | SUPRATENTORIAL BRAIN-TUMORS | SOCIOECONOMIC DISPARITIES | RESECTION | IMPROVED SURVIVAL | CARE | CLINICAL NEUROLOGY | ONCOLOGY | EXTENT | PROVIDER | ASSOCIATION | Travel | Hospitals | Mortality | Surgery | Patients
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Nature Communications, ISSN 2041-1723, 08/2016, Volume 7, Issue 1, p. 12498
Resistance to oestrogen-deprivation therapy is common in oestrogen-receptor- positive (ER + ) breast cancer. To better understand the contributions of tumour... 
HETEROGENEITY | LUNG-CANCER | IMPROVED SURGICAL OUTCOMES | PHASE-II TRIAL | WHOLE-GENOME | EVOLUTION | MULTIDISCIPLINARY SCIENCES | ENDOCRINE-THERAPY | RESISTANCE | ACUTE MYELOID-LEUKEMIA | MUTATIONS
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 11/2011, Volume 103, Issue 22, pp. 1656 - 1664
Journal Article
Obesity Surgery, ISSN 0960-8923, 6/2018, Volume 28, Issue 6, pp. 1461 - 1472
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 1/2010, Volume 119, Issue 2, pp. 379 - 390
Mutations in the alpha catalytic subunit of phosphoinositol-3-kinase (PIK3CA) occur in ~30% of ER positive breast cancers. We therefore sought to determine the... 
Somatic mutation | Prognosis | Medicine & Public Health | Phosphatidyl-inositol-3-kinase | Neoadjuvant endocrine therapy | Oncology | Estrogen receptor-positive breast cancer | IMPROVED SURGICAL OUTCOMES | PTEN LOSS | PIK3CA MUTATIONS | TAMOXIFEN | PROLIFERATION | PHOSPHOINOSITIDE 3-KINASE | PHASE-II TRIAL | ONCOLOGY | LETROZOLE | INHIBITOR | CORRELATE | Phosphorylation | Exons | Humans | Gene Expression Regulation, Neoplastic | Receptors, Estrogen - analysis | Receptors, Progesterone - analysis | Breast Neoplasms - chemistry | Breast Neoplasms - enzymology | Time Factors | Antineoplastic Agents, Hormonal - therapeutic use | Female | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Breast Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Breast Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases | Ki-67 Antigen - analysis | Breast Neoplasms - pathology | Proto-Oncogene Proteins c-akt - analysis | Cell Proliferation - drug effects | Mutation | Receptor, ErbB-2 - analysis | Neoplasm Staging | Clinical Trials, Phase II as Topic | Care and treatment | Inositol | Analysis | Estrogen | Adjuvant treatment | Phenols | Breast cancer | Health aspects | Cancer
Journal Article
Journal Article